Home
MGTX
MGTX News

Latest MeiraGTx Holdings plc (MGTX) News on July 12, 2025

MT Newswires

2 months ago

Chardan Adjusts MeiraGTx Price Target to $35 From $38, Maintains Buy Rating

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

GlobeNewswire

2 months ago

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates

Zacks

2 months ago

MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

GlobeNewswire

2 months ago

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires

2 months ago

MeiraGTx Says FDA Granted RMAT Designation to AAV-GAD for Treating Parkinson's; Shares Up Pre-Bell

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease

GlobeNewswire

2 months ago

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease

MT Newswires

2 months ago

Top Premarket Decliners

Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?

Zacks

3 months ago

Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?

US High Growth Tech Stocks to Watch in 2023

Simply Wall St.

3 months ago

US High Growth Tech Stocks to Watch in 2023

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

3 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?

Zacks

4 months ago

AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?

MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future

Simply Wall St.

4 months ago

MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future

MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment

Insider Monkey

4 months ago

MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment

MT Newswires

4 months ago

RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk

MeiraGTx and Hologen launch AI-backed gene therapy venture

Pharmaceutical Technology

4 months ago

MeiraGTx and Hologen launch AI-backed gene therapy venture

MT Newswires

4 months ago

MeiraGTx Shares Soar After Joint Venture Deal With Hologen

MT Newswires

4 months ago

Top Midday Gainers

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

BioPharma Dive

4 months ago

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

GlobeNewswire

4 months ago

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process

GlobeNewswire

4 months ago

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process

High Growth Tech Stocks In The United States Spotlighting Three Leaders

Simply Wall St.

5 months ago

High Growth Tech Stocks In The United States Spotlighting Three Leaders

MeiraGTx seeks UK approval after gene therapy restores sight in children born blind

Pharmaceutical Technology

5 months ago

MeiraGTx seeks UK approval after gene therapy restores sight in children born blind

MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy

GlobeNewswire

5 months ago

MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy

MeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 25% stake, while 21% is held by institutions

Simply Wall St.

5 months ago

MeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 25% stake, while 21% is held by institutions

MT Newswires

6 months ago

MeiraGTx Says FDA Grants Rare Pediatric Disease Designation to Eye Disorder Drug

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations

GlobeNewswire

6 months ago

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations

Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Insider Monkey

6 months ago

Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

High Growth Tech Stocks in the United States

Simply Wall St.

6 months ago

High Growth Tech Stocks in the United States

MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey

6 months ago

MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?

Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years

Simply Wall St.

7 months ago

Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years

MeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1

TipRanks

7 months ago

MeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1

MT Newswires

7 months ago

MeiraGTx's Xerostomia Drug Gets FDA Regenerative Medicine Advanced Therapy Designation

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

GlobeNewswire

7 months ago

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

PR Newswire

8 months ago

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

8 months ago

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates

Zacks

8 months ago

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates

MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates

GlobeNewswire

8 months ago

MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress

GlobeNewswire

9 months ago

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress

High Growth Tech Stocks to Watch in October 2024

Simply Wall St.

9 months ago

High Growth Tech Stocks to Watch in October 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study

Clinical Trials Arena

9 months ago

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study

Zacks

9 months ago

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results

TipRanks

9 months ago

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?

Zacks

9 months ago

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints

Benzinga

9 months ago

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints

MT Newswires

9 months ago

MeiraGTx's Parkinson's Disease Therapy Shows Improvement in Motor Examination Score

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

GlobeNewswire

9 months ago

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference

GlobeNewswire

9 months ago

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook

Simply Wall St.

9 months ago

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

Zacks

10 months ago

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.

10 months ago

Exploring Three High Growth Tech Stocks in the United States

Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts?

Insider Monkey

10 months ago

Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts?

MT Newswires

a year ago

RBC Adjusts Price Target on MeiraGTx Holdings to $9 From $11, Maintains Outperform Rating, Speculative Risk

MT Newswires

a year ago

MeiraGTx Holdings Raises $50 Million Offering Led by Sanofi

MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates

Zacks

a year ago

MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates

MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results

GlobeNewswire

a year ago

MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results

MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi

GlobeNewswire

a year ago

MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi

MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 86% if they invested five years ago

Simply Wall St.

a year ago

MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 86% if they invested five years ago

Here's Why It's Unlikely That MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Will See A Pay Rise This Year

Simply Wall St.

a year ago

Here's Why It's Unlikely That MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Will See A Pay Rise This Year

Ireland – the jewel in the life sciences crown?

Medical Device Network

a year ago

Ireland – the jewel in the life sciences crown?

Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher

Simply Wall St.

a year ago

Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher

MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results

GuruFocus.com

a year ago

MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results

MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)

Simply Wall St.

a year ago

MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)

MeiraGTx Reports First Quarter 2024 Financial and Operational Results

GlobeNewswire

a year ago

MeiraGTx Reports First Quarter 2024 Financial and Operational Results

MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?

Simply Wall St.

a year ago

MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?

MeiraGTx to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

MeiraGTx to Participate in Upcoming Investor Conferences

MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference

GlobeNewswire

a year ago

MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference

GuruFocus.com

a year ago

MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023

MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates

Zacks

a year ago

MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates

MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates

GlobeNewswire

a year ago

MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates

MeiraGTx Holdings plc (NASDAQ:MGTX) stock most popular amongst private equity firms who own 28%, while individual investors hold 26%

Simply Wall St.

a year ago

MeiraGTx Holdings plc (NASDAQ:MGTX) stock most popular amongst private equity firms who own 28%, while individual investors hold 26%

MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

GlobeNewswire

a year ago

MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Zacks

a year ago

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Reuters

a year ago

Freight through Suez Canal down 45% since Houthi attacks - UNCTAD

The Santa Fe New Mexican

a year ago

Controversial proposed oil and gas bill changes pass first committee

Bid to overhaul New Mexico oil and gas regulations clears first hurdle amid litigation

Associated Press Finance

a year ago

Bid to overhaul New Mexico oil and gas regulations clears first hurdle amid litigation

Western Alliance (WAL) Q4 Earnings and Revenues Miss Estimates

Zacks

a year ago

Western Alliance (WAL) Q4 Earnings and Revenues Miss Estimates

Midland States Bancorp (MSBI) Q4 Earnings and Revenues Beat Estimates

Zacks

a year ago

Midland States Bancorp (MSBI) Q4 Earnings and Revenues Beat Estimates

Nano Dimension Renews its Limited Duration Rights Plan

GlobeNewswire

a year ago

Nano Dimension Renews its Limited Duration Rights Plan

Beware the AI Hype: 3 Stocks to Sell Before They Tumble

InvestorPlace

a year ago

Beware the AI Hype: 3 Stocks to Sell Before They Tumble

Petco and Nationwide® launch co-branded pet insurance product on petco.com

PR Newswire

a year ago

Petco and Nationwide® launch co-branded pet insurance product on petco.com

Is Arcos Dorados (ARCO) a Great Value Stock Right Now?

Zacks

a year ago

Is Arcos Dorados (ARCO) a Great Value Stock Right Now?

Those who invested in Coastal Financial (NASDAQ:CCB) five years ago are up 171%

Simply Wall St.

a year ago

Those who invested in Coastal Financial (NASDAQ:CCB) five years ago are up 171%

Algoma Steel Reports Incident at Coke-Making Plant

GlobeNewswire

a year ago

Algoma Steel Reports Incident at Coke-Making Plant

Regenxbio Inc President and CEO Kenneth Mills Sells 45,000 Shares

GuruFocus.com

a year ago

Regenxbio Inc President and CEO Kenneth Mills Sells 45,000 Shares

GlobeNewswire

a year ago

Titan Machinery Elects New Board Member

Jewelry Looking Grimy? Here’s How to Clean It at Home

The Wall Street Journal

a year ago

Jewelry Looking Grimy? Here’s How to Clean It at Home

Redwood Trust Prices $60.0 Million Senior Notes Offering

Business Wire

a year ago

Redwood Trust Prices $60.0 Million Senior Notes Offering

Ardmore Shipping (ASC) Suffers a Larger Drop Than the General Market: Key Insights

Zacks

a year ago

Ardmore Shipping (ASC) Suffers a Larger Drop Than the General Market: Key Insights

BlueLinx Announces Expansion of Distribution Partnership with Huber Engineered Woods

GlobeNewswire

a year ago

BlueLinx Announces Expansion of Distribution Partnership with Huber Engineered Woods

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

PR Newswire

a year ago

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

PR Newswire

a year ago

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Why AI Automation Stock Symbotic Zoomed 330% in 2023

Motley Fool

a year ago

Why AI Automation Stock Symbotic Zoomed 330% in 2023

Titan Machinery (TITN) Buys Scott Supply to Expand Footprint

Zacks

a year ago

Titan Machinery (TITN) Buys Scott Supply to Expand Footprint

3 Under-the-Radar Tech Stocks for Stunning Returns in 2024

InvestorPlace

2 years ago

3 Under-the-Radar Tech Stocks for Stunning Returns in 2024

GlobeNewswire

2 years ago

Titan Machinery Announces Acquisition of Scott Supply, Co.

Brookdale (BKD) Sees Growth in December 2023 Occupancy Volumes

Zacks

2 years ago

Brookdale (BKD) Sees Growth in December 2023 Occupancy Volumes

TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024

GlobeNewswire

2 years ago

TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024

Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet

Zacks

2 years ago

Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet

Share on Social Networks: